![Andrew O.](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew O.
Directeur en chef des Investissements chez
POLARYX THERAPEUTICS, INC.
Fortune : 756 $ au 31/08/2026
Profil
Andrew John O. is currently Chief Investment Officer at Polaryx Therapeutics, Inc., a position starting in 2026.
Formerly, Mr. O.
was Senior Portfolio Manager of Asian Equities at Manulife Investment Management (Hong Kong) Ltd. from 2013 to 2022.
Mr. O.
also worked as a Representative at FrontPoint Management (Hong Kong) Ltd.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/07/2026 | 376 ( 0 % ) | 756 $ | 31/08/2026 |
Postes actifs de Andrew O.
| Sociétés | Poste | Début |
|---|---|---|
| POLARYX THERAPEUTICS, INC. | Directeur en chef des Investissements | 01/01/2022 |
Anciens postes connus de Andrew O.
| Sociétés | Poste | Fin |
|---|---|---|
Manulife Investment Management (Hong Kong) Ltd.
 Manulife Investment Management (Hong Kong) Ltd. Investment ManagersFinance Manulife-HK is an active manager which offers locally managed Asian equity, fixed-income and global strategies based on fundamental research and quantitative modeling and analysis drawn from the parent firm in Canada. The firm's equity teams focus on delivering alpha via differentiated investment processes driven by proprietary fundamental research and a long-term orientation. They utilize multiple sources of alpha based on a fundamental, research-driven investment approach across traditional and non-traditional market sectors. | Gestionnaire de Portefeuille-Actions | 17/01/2022 |
FrontPoint Management (Hong Kong) Ltd.
 FrontPoint Management (Hong Kong) Ltd. Investment ManagersFinance FrontPoint-Hong Kong is an active, research-based manager which employs multiple strategies, including a Japan long/short strategy and an Asia Pacific (including Japan) strategy. They utilize a combination of fundamental analysis and bottom-up stock picking to make investments. The firm believes that the FrontPoint investment management platform and equity-oriented culture enables them to enhance their primary research capabilities and maintain a sustainable competitive edge across Asian markets. They collaborate with other FrontPoint managers to share information and focus on applying FrontPoint's portfolio management software development capabilities and independent risk management framework to manage investments. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Manulife Investment Management (Hong Kong) Ltd.
Manulife Investment Management (Hong Kong) Ltd. Investment ManagersFinance Manulife-HK is an active manager which offers locally managed Asian equity, fixed-income and global strategies based on fundamental research and quantitative modeling and analysis drawn from the parent firm in Canada. The firm's equity teams focus on delivering alpha via differentiated investment processes driven by proprietary fundamental research and a long-term orientation. They utilize multiple sources of alpha based on a fundamental, research-driven investment approach across traditional and non-traditional market sectors. | Finance |
FrontPoint Management (Hong Kong) Ltd.
FrontPoint Management (Hong Kong) Ltd. Investment ManagersFinance FrontPoint-Hong Kong is an active, research-based manager which employs multiple strategies, including a Japan long/short strategy and an Asia Pacific (including Japan) strategy. They utilize a combination of fundamental analysis and bottom-up stock picking to make investments. The firm believes that the FrontPoint investment management platform and equity-oriented culture enables them to enhance their primary research capabilities and maintain a sustainable competitive edge across Asian markets. They collaborate with other FrontPoint managers to share information and focus on applying FrontPoint's portfolio management software development capabilities and independent risk management framework to manage investments. | Finance |
Polaryx Therapeutics, Inc.
 Polaryx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that engages in discovery, development and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders | Commercial Services |
